Loading clinical trials...
Loading clinical trials...
The prevalence of sleep disorders has achieved epidemic proportions in Western countries. Despite this, assessment and treatment of sleep disorders remains infrequent, unattainable, and often costly. Dayzz is aware of the need for easily accessible, user-friendly, and affordable treatment strategies for known sleep conditions. This research proposes a randomized controlled outcome study aimed to validate a, digitized, cost-effective mobile app which assesses and manages insomnia and CPAP adherence in persons with sleep apnea. The app's sleep training protocols recommend life-style and behavioral changes and tracks these changes with the aim of improving sleep and well-being. In this study, the dayzz app digital treatment protocol will be compared to the standard treatment for these sleep conditions by a sleep professional.
Age
21 - 65 years
Sex
ALL
Healthy Volunteers
No
Carmel Hospital
Haifa, Israel
Start Date
January 29, 2019
Primary Completion Date
December 30, 2020
Completion Date
December 30, 2020
Last Updated
August 19, 2021
125
ACTUAL participants
Dayzz mobile sleep training
BEHAVIORAL
Treatment as usual
OTHER
Lead Sponsor
Dayzz Live Well Ltd.
Collaborators
NCT06430957
NCT06032377
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07292922